FDA Will Publicize EUA Data, Information As GAO Calls For Transparency

FDA will publicly post its reviews of data and information supporting emergency use authorization decisions for drugs and biologics, including vaccines, as part of the agency’s COVID-19 response, FDA chief Stephen Hahn announced Tuesday (Nov. 17), just a few hours before the Government Accountability Office issued a report calling for FDA to be more transparent about its sometimes inconsistent EUA reviews and decisions. A spokesperson for GAO told Inside Health Policy that FDA’s announcement seems to align with the...